6533b85ffe1ef96bd12c24bd

RESEARCH PRODUCT

Linezolidtherapie bei zwei Frühgeborenen mit nekrotisierender Enterokolitis und Infektion durch Vancomycin-resistente Enterokokken

R. HuthU. KlingkowskiMarkus KnufP. Habermehl

subject

Pediatricsmedicine.medical_specialtymedicine.drug_classAntibioticsDrug resistancemedicine.disease_causechemistry.chemical_compoundPharmacotherapymedicineheterocyclic compoundsVancomycin-resistant EnterococcusEnterocolitisbiologybusiness.industryorganic chemicalsbiochemical phenomena metabolism and nutritionbacterial infections and mycosesmedicine.diseasebiology.organism_classificationEnterococcuschemistryPediatrics Perinatology and Child HealthNecrotizing enterocolitisLinezolidbacteriamedicine.symptombusiness

description

The use of the antibiotic Linezolid in two premature babies with necrotizing enterocolitis and infection with vancomycin-resistant enterococcus is described. Therapy with Linezolid in cause of necrotizing enterocolitis is an exception. Actually there are no proven recommendations for the use in this age group. Despite the successfully results more investigations for the use of linezolid in newborns and prematures are necessary.

https://doi.org/10.1055/s-2004-817683